Get the full picture
Sign in to uncover key details.
Trellis Bioscience
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
702 Marshall St Ste 301, Redwood City, C...Phone Number
(408) 772-8049Website
www.trellisbio.comRevenue
<$5 MillionIndustry
About Trellis Bioscience
Trellis Bioscience specializes in the discovery and development of human monoclonal antibodies (mAbs) for the treatment of infectious diseases and cancer. Utilizing their proprietary CellSpot platform, they have developed a pipeline of products, including TRL1068, aimed at addressing complex medical challenges such as prosthetic joint infections and various viral infections. Their intended clients include healthcare providers and patients suffering from serious infections and cancer, with a focus on improving treatment outcomes and reducing the need for invasive procedures. The company is committed to advancing clinical evaluations and leveraging innovative technologies to enhance therapeutic options in the pharmaceutical industry.Explore more
Trellis Bioscience Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Trellis Bioscience
Compare insights from companies similar to Trellis Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$5.7M
11-50
Private
-
2001
MF
Mark FeuerbachTreasury, Financial Planning & Analysis Vice President, Investor Relations
Trellis Bioscience Tech Stack
A closer look at the technologies used by Trellis Bioscience
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Trellis Bioscience
Sign Up For FreeTo access detailed company insights
Trellis Bioscience specializes in the discovery and development of human monoclonal antibodies (mAbs) for the treatment of infectious diseases and cancer. Utilizing their proprietary CellSpot platform, they have developed a pipeline of products, including TRL1068, aimed at addressing complex medical challenges such as prosthetic joint infections an... Read More
